A
research study titled, “Deep Brain Stimulation Market by Application - Global
Industry Analysis and Forecast to 2025” published by Crystal Market Research,
states that the deep brain stimulation market is projected to be around
$3.2billion by 2025.
Hundreds
of millions of people all over the world are affected by neurological
disorders. As per Parkinson’s Disease Foundation, more than 10 million people
all over the world are affected by Parkinson’s disease. Deep brain stimulation
(DBS) is used for treating different neurological diseases ranging from
dystonia, epilepsy, obsessive compulsive disorder to Parkinson’s disease.
Rising awareness about neurological diseases along with the efficiency of
accessing the brain through DBS is contributing to the market growth. As more
professionals are adopting DBS over drug therapy to avoid side effects, the
market is expected to exhibit significant growth during the forecast period.
DBS can be used to restore movements in cases of neurological injuries that can
result into disability or paralysis. Also, DBS procedures have fewer
complications as compared to procedures such as pallidotomy owing to the
non-destructive nature of the DBS procedures.
Browse full research report with TOC @: https://www.crystalmarketresearch.com/report/deep-brain-stimulation-market
Parkinson’s disease segment
accounted for more than three-fourth share of theglobal DBS market in 2016, due
to growing prevalence of this disease. According to the Parkinson’s Disease
Foundation, around 60,000 patients are diagnosed with Parkinson’s disease every
year in the U.S. Men are one and a half times more susceptible to Parkinson’s
disease as compared to women. Although DBS is not a permanent cure for
Parkinson’s disease it can surely control the symptoms to a great extent
improving the quality of life of the affected patients. According to WHO, more
than 50 million people across the world are suffering from epilepsy. DBS has
significant applications in the treatment of epilepsy by reducing the chances
of a seizure.
North
America held a significant share of the global deep brain stimulation market in
2016, due to the presence of major vendors in the U.S. and advanced healthcare
research and development facilities conducting research on the treatment of
neurological diseases. The Asia-Pacific DBS market will show considerable
growth during the forecast period. Deep brain stimulation procedure acts as a
minimally invasive alternative to long term administration of medication for
Parkinson’s patients. This could be beneficial with respect to affordability
for patients in emerging economies.
Some
of the key players in DBS market are St. Jude Medical, Medtronic Plc.,
Enteromedics, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Zynex,
and Cyberonics. These players focus on strategic acquisitions to expand their
product portfolio and sustain their positions in the market. For instance, in
August 2014, Medtronic acquired Sapiens Steering Brain Stimulation, to
strengthen its capabilities to carry out more precise stimulation of intended
target in the brain.
To request a sample copy or
view summary of this report, click the link below:
Key
Findings of the Research Study:
- Patient’s suffering from
Parkinson’s disease experience improved motor functions as a result of
DBS. People affected by epilepsy who are not suitable candidates for
respective surgery, witness significant reduction in seizures.
- Parkinson’s disease market held a
major share of the global DBS market due to the benefits offered by DBS
for controlling the symptoms of Parkinson’s disease and allowing the
patients to lead a better life with improved mobility.
- North America dominated the global
DBS market in 2016, due to high adoption of technologically advanced
products and availability of advanced healthcare infrastructure.
- Asia-Pacific market will exhibit
promising growth over the forecast period with rapid adoption of DBS as a
minimally invasive procedure affordable in this region.
Buy
now this report @: https://www.crystalmarketresearch.com/checkout/HC058
No comments:
Post a Comment